Exact Sciences Corporation vs Pfizer, Inc. — Stock Comparison

EXAS
Exact Sciences Corporation
$104.91
▲ 0.00%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.7/10

Q·Score Breakdown

4.7
Bearish
Overall
6.5
Neutral
2.9
Quality
7.4
6.9
Health
7
6.5
Growth
5.6
4.2
Valuation
6.7
3.3
Sentiment
5.2
EXAS

Healthy balance sheet and financial position.

currently unprofitable (-6% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $106.30 (+1.3%)
10 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

EXAS
PFE
Trailing P/E
19.4×
55.2×
Forward P/E
9.4×
-6.4%
Profit Margin
12.4%
69.7%
Gross Margin
75.8%
-8.7%
ROE
8.9%
23.1%
Revenue Growth
-1.2%
Earnings Growth
1.44
Beta
0.39
Price / Book
$20.0B
Market Cap
$149.8B
$39 – $105
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →